LabTech(SH:688056)2023-10-31 11:26Group 1: Company Overview - Beijing Leibotai Technology Co., Ltd. is actively expanding its R&D personnel to support new product development, particularly by recruiting high-end talent [2] - The company is currently focusing on the orderly advancement of all new projects [2] Group 2: Key Personnel - Dr. Cui Jianfeng has been appointed as the Deputy General Manager of the Mass Spectrometry Division, responsible for product development and management [3] - Dr. Cui has extensive experience in the lifecycle of mass spectrometry products, having previously worked at Thermo Fisher [3] Group 3: Customer Base Changes - The customer base remains primarily composed of government departments, research institutions, universities, third-party testing firms, and corporate clients [3] - There has been a slight decrease in revenue from government departments, while the share from corporate clients, research institutions, and universities has increased compared to the previous year [3] Group 4: R&D Expenditure - The increase in R&D expenses in Q3 2023 is attributed to new key projects and the hiring of high-end R&D personnel, leading to higher salary costs [3] - Additional costs include materials and depreciation of R&D instruments [3] Group 5: Product Validation - The company does not require extensive product validation for new semiconductor clients, as the ICP-MS product has been positioned as a premium offering since its launch in May 2021 [3] Group 6: Collaborations - The company has signed two significant procurement contracts with the China National Institute of Metrology, focusing on automated radiochemical analysis systems and plasma mass spectrometry [3]